DD202012A5 - Verfahren zur herstellung von 9-amino-1-hydroxyoctahydrobezo (c) chinolinen und ihren derivaten - Google Patents

Verfahren zur herstellung von 9-amino-1-hydroxyoctahydrobezo (c) chinolinen und ihren derivaten Download PDF

Info

Publication number
DD202012A5
DD202012A5 DD81232067A DD23206781A DD202012A5 DD 202012 A5 DD202012 A5 DD 202012A5 DD 81232067 A DD81232067 A DD 81232067A DD 23206781 A DD23206781 A DD 23206781A DD 202012 A5 DD202012 A5 DD 202012A5
Authority
DD
German Democratic Republic
Prior art keywords
hydrogen
formula
methyl
carbon atoms
compound
Prior art date
Application number
DD81232067A
Other languages
German (de)
English (en)
Inventor
Johnson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DD202012A5 publication Critical patent/DD202012A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • C07D221/12—Phenanthridines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
DD81232067A 1980-07-28 1981-07-24 Verfahren zur herstellung von 9-amino-1-hydroxyoctahydrobezo (c) chinolinen und ihren derivaten DD202012A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/173,207 US4309545A (en) 1980-07-28 1980-07-28 Oximino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof

Publications (1)

Publication Number Publication Date
DD202012A5 true DD202012A5 (de) 1983-08-24

Family

ID=22630983

Family Applications (1)

Application Number Title Priority Date Filing Date
DD81232067A DD202012A5 (de) 1980-07-28 1981-07-24 Verfahren zur herstellung von 9-amino-1-hydroxyoctahydrobezo (c) chinolinen und ihren derivaten

Country Status (29)

Country Link
US (1) US4309545A (cs)
EP (1) EP0045171B1 (cs)
JP (1) JPS57112372A (cs)
KR (1) KR850000273B1 (cs)
AR (1) AR230988A1 (cs)
AT (1) ATE11775T1 (cs)
AU (1) AU525944B2 (cs)
CA (1) CA1178274A (cs)
CS (1) CS228515B2 (cs)
DD (1) DD202012A5 (cs)
DE (1) DE3168891D1 (cs)
DK (1) DK334581A (cs)
EG (1) EG15535A (cs)
ES (1) ES8301926A1 (cs)
FI (1) FI812338L (cs)
GR (1) GR75283B (cs)
GT (1) GT198170557A (cs)
HU (1) HU185133B (cs)
IE (1) IE51426B1 (cs)
IL (1) IL63423A0 (cs)
IN (1) IN158867B (cs)
NO (2) NO812557L (cs)
NZ (1) NZ197856A (cs)
PH (1) PH17281A (cs)
PL (1) PL133928B1 (cs)
PT (1) PT73440B (cs)
SU (1) SU1217254A3 (cs)
YU (1) YU185181A (cs)
ZA (1) ZA815128B (cs)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4642373A (en) * 1982-03-16 1987-02-10 Pfizer Inc. Substituted dodecahydrotripheylenes, and decahydropyrrolo[1,2-f]phenanthridines as CNS agents
US4473704A (en) * 1982-03-16 1984-09-25 Pfizer Inc. Substituted dodecahydrotriphenylenes, decahydro-1H-cyclopenta[1]phenanthrenes, decahydro-1H-pyrido[1,2-f]phenanthridines and decahydropyrrolo[1,2-f]phenanthridines as CNS agents
US4920221A (en) * 1982-03-16 1990-04-24 Pfizer Inc. Substituted decahydro-1H-pyrido[1,2-f]phenanthridines and decahydropyrrolo[1,2-f]phenanthridines
US5605906A (en) * 1995-03-24 1997-02-25 Merck Frosst Canada, Inc. Cannabinoid receptor agonists
BR9707233A (pt) * 1996-01-31 1999-07-20 Byk Gulden Lomberg Chem Fab Fenantridinas
SI0889886T1 (en) * 1996-03-26 2003-02-28 Altana Pharma Ag Novel phenanthridines substituted in the 6 position
US6127378A (en) * 1996-03-26 2000-10-03 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenanthridines substituted in the 6 position
US5776482A (en) * 1996-03-29 1998-07-07 University Of Iowa Research Foundation Tetrahydroquinoline analogues for use in glaucoma treatment
WO1999005112A1 (en) * 1997-07-25 1999-02-04 Byk Gulden Lomberg Chemische Fabrik Gmbh Substituted 6-alkylphenanthridines
JP2001510827A (ja) * 1997-07-25 2001-08-07 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング 置換６−フェニルフェナントリジン
AU3910700A (en) 1999-03-22 2000-10-09 Immugen Pharmaceuticals, Inc. Treatment of immune diseases
US6566560B2 (en) 1999-03-22 2003-05-20 Immugen Pharmaceuticals, Inc. Resorcinolic compounds
US20060084021A1 (en) * 2004-09-10 2006-04-20 Kubicek Chris A Wick holder
WO2002026224A2 (en) * 2000-09-28 2002-04-04 Immugen Pharmaceuticals, Inc. Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
US6541510B2 (en) * 2000-09-28 2003-04-01 Immugen Pharmaceuticals, Inc. Antiviral methods and compounds
WO2003080043A1 (en) * 2002-03-18 2003-10-02 Immugen Pharmaceuticals, Inc. Topical formulations of resorcinols and cannibinoids and methods of use
EA012668B1 (ru) * 2004-05-25 2009-12-30 Отера Холдинг, Инк. Окулоселективные лекарственные средства и пролекарства

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3839441A (en) * 1969-10-27 1974-10-01 Hoffmann La Roche Intermediates for partially hydrogenated phenanthridines
US3878219A (en) * 1973-07-13 1975-04-15 Abbott Lab 5H-{8 1{9 benzopyrano{8 3,4-d{9 pyridines
US3928598A (en) * 1973-11-05 1975-12-23 Lilly Co Eli Hexahydro-dibenzo{8 b,d{9 pyran-9-ones as an anti-anxiety drug
US4087545A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiemetic drugs
SE7704749L (sv) * 1976-05-17 1977-12-05 Pfizer Kinoliner och forfarande och mellanprodukter for framstellning derav
HU180916B (hu) 1976-05-17 1983-05-30 Pfizer Eljárás benzo[c]kinolin-származékok előállítására
US4152450A (en) * 1978-02-17 1979-05-01 Eli Lilly And Company 9-Amino-dibenzopyrans

Also Published As

Publication number Publication date
HU185133B (en) 1984-12-28
EP0045171A2 (en) 1982-02-03
US4309545A (en) 1982-01-05
CA1178274A (en) 1984-11-20
FI812338A7 (fi) 1982-01-29
ATE11775T1 (de) 1985-02-15
NO812557L (no) 1982-01-29
NZ197856A (en) 1984-10-19
ZA815128B (en) 1982-07-28
GR75283B (cs) 1984-07-13
PH17281A (en) 1984-07-06
PT73440A (en) 1981-08-01
IL63423A0 (en) 1981-10-30
AR230988A1 (es) 1984-08-31
CS228515B2 (en) 1984-05-14
DK334581A (da) 1982-01-29
PT73440B (en) 1983-06-20
AU525944B2 (en) 1982-12-09
EP0045171B1 (en) 1985-02-13
YU185181A (en) 1983-12-31
SU1217254A3 (ru) 1986-03-07
PL133928B1 (en) 1985-07-31
EP0045171A3 (en) 1982-04-28
KR850000273B1 (ko) 1985-03-15
FI812338L (fi) 1982-01-29
NO854454L (no) 1985-01-29
GT198170557A (es) 1983-01-12
JPS57112372A (en) 1982-07-13
ES504323A0 (es) 1982-12-16
EG15535A (en) 1986-09-30
KR830006217A (ko) 1983-09-20
ES8301926A1 (es) 1982-12-16
PL232331A1 (en) 1983-09-26
IN158867B (cs) 1987-02-07
DE3168891D1 (en) 1985-03-28
AU7343481A (en) 1982-05-06
IE811686L (en) 1982-01-28
IE51426B1 (en) 1986-12-24

Similar Documents

Publication Publication Date Title
DD202012A5 (de) Verfahren zur herstellung von 9-amino-1-hydroxyoctahydrobezo (c) chinolinen und ihren derivaten
DE2849224C2 (de) 1,9-Dihydroxyoctahydrophenanthrene, 1-Hydroxyoctahydrophenanthren-9-one, 1-Hydroxyhexahydrophenanthren-9-one sowie Derivate hiervon und Zwischenprodukte zu ihrer Herstellung und diese enthaltende Arzneimittel
US4260764A (en) 9-Hydroxyoctahydrobenzo [C] quinolines and intermediates therefor
DD264919A5 (de) Verfahren zur herstellung von 5-hydroxy-3-aminochromanen
DE3023626A1 (de) 1,9-dihydroxyoctahydrobenzo eckige klammer auf c eckige klammer zu chinoline und 1-hydroxyhexahydrobenzo eckige klammer auf c eckige klammer zu chinolin-9 (8h)- one als antiemetika
DE69008542T2 (de) Chinolinderivate, ihre herstellung und verwendung.
EP0415065A1 (de) Chromanderivate
DD211559A5 (de) Verfahren zur herstellung bicyclischer, benzokondensierter verbindungen
DE2722383C2 (cs)
DE3209304C2 (cs)
DE2806909C2 (cs)
DD210270A5 (de) Verfahren zur herstellung substituierter hexahydropyrrolo (1,2-a)-chinolin-, hexahydro-1h-pyrido (1,2-a) chinolin-, hexahydrobenzo(e)inden- und octahydrophenanthrenzns-mittel
EP0082461A2 (de) Substituierte Phenoxyalkanolamine und Phenoxyalkanol-cycloalkylamine, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende pharmazeutische Zubereitungen und Zwischenprodukte
US4405626A (en) 9-Hydroxyoctahydrobenzo(c)quinolines analgesic compositions containing them and processes for producing analgesic with them
CH642941A5 (de) Therapeutisch wirksame 2-aminotetralin-derivate und verfahren zu ihrer herstellung.
DD209451A5 (de) Verfahren zur herstellung von octahydrobenz(f)isochinoline
US4351833A (en) 9-Amino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof as analgesics and anti-emetics
HU180916B (hu) Eljárás benzo[c]kinolin-származékok előállítására
US4340737A (en) 9-Hydroxyoctahydrobenzo[C]quinolines and intermediates therefor
CH636076A5 (de) Benzylalkoholderivate und verfahren zu deren herstellung.
EP0000013B1 (de) 4-Phenyl-8-amino-tetrahydroisochinoline, diese enthaltende pharmazeutische Präparate und Verfahren zur Herstellung dieser Präparate
DE1668208C3 (de) Tricyclische Amine, deren Salze, Verfahren zu deren Herstellung und diese enthaltende Mittel
JPS6026387B2 (ja) シンナミルモラノリン誘導体
DE2747987C2 (cs)
DE2333846A1 (de) Aminopropanolderivate, ihre salze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel